3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
13
Carcinoma, Non-Small-Cell Lung
12
Brain Neoplasms
9
Neoplasm Metastasis
7
Lung Neoplasms
6
Breast Neoplasms
5
Pancreatic Neoplasms
4
Urinary Bladder Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Spinal Cord Diseases
1
Spinal Cord Compression
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Prostate Cancer Metastatic Disease
1
Papillomavirus Infections
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Oligometastatic Prostate Cancer
1
Neoplasms
1
NSCLC
1
Mouth Neoplasms
1
Meningioma
1
Melanoma
1
Lymphatic Metastasis
1
Laryngeal Neoplasms
1
Interventions
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Radiosurgery
×
30 days
×
Clear all
No trials found.